← FDA Warning Letters

Purushothaman Damodara Kumaran, M.D.

FDA Warning Letter · 2026-01-13 · Center for Drug Evaluation and Research (CDER)

Letter

Company
Purushothaman Damodara Kumaran, M.D.
Posted Date
2026-01-13
Letter Issue Date
2025-12-22
Issuing Office
Center for Drug Evaluation and Research (CDER)

Subject

In Vivo Bioavailability-Bioequivalence Studies – Clinical

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown